Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.8 CHF | -0.28% | +3.39% | +9.37% |
May. 13 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.37% | 209B | |
+29.98% | 682B | |
+31.69% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.49% | 240B | |
-9.00% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Receives a Buy rating from Jefferies